Merck CEO: When it comes to drug pricing and politics, pharma's in the 'crosshairs'

It’s no secret that pharma’s a familiar political target, and with 2020 elections getting into gear, Merck CEO Ken Frazier knows his industry faces challenges in the year ahead.

Speaking at Yahoo Finance’s All Markets Summit, Frazier said pharma is “right in the crosshairs” as politicians and lawmakers discuss ways to lower prescription drug prices. Presidential candidates have voiced various ideas to fight high prices, and Frazier said some are “legitimate plans” while others will “hurt innovation,” as quoted by Yahoo Finance.